NSTM NovelStem International Corp.
Retail-Retail Stores, NEC · OTC · SEC CIK 912544 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-113.6%
TTM EPS YoY-100.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE—
ROA-1,347.4%
ROIC (approx.)—
Asset turnover—
Leverage & solvency
Liabilities / assets6,752.9%
Debt / equity—
Current ratio0.01x
Interest coverage3.42x
Cash quality & payout
Operating cash flow / net income0.74x
Accruals ratio-352.9%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | — | — | — | — | — |
| SG&A expense | $238,755 | $880,947 | $665,277 | $744,434 | $495,535 |
| Operating income | -$238,755 | -$927,922 | -$3.53M | -$422,434 | -$495,535 |
| Interest expense | $36,000 | $425,417 | $99,023 | $11,018 | $6,825 |
| Pretax income | $2.37M | -$1.44M | -$3.88M | -$433,452 | -$502,360 |
| Net income | $2.38M | -$3.23M | -$4.19M | -$765,730 | -$1.35M |
| EPS (basic) | 0.05 | -0.07 | -0.09 | -0.02 | -0.03 |
| EPS (diluted) | 0.05 | -0.07 | -0.09 | -0.02 | — |
| Weighted avg. shares (diluted) | 47.80M | 46.88M | 46.88M | 46.88M | 44.26M |
| Balance sheet | |||||
| Cash & equivalents | $333 | $6,099 | $53,063 | $6,346 | $8,666 |
| Receivables | — | $10,500 | — | $12,000 | — |
| Current assets | $15,786 | $31,871 | $86,603 | $58,907 | $36,982 |
| Total assets | $15,786 | $160,111 | $2.25M | $2.29M | $2.61M |
| Current liabilities | $2.16M | $5.30M | $346,480 | $64,876 | $193,202 |
| Short-term debt | $1.30M | $4.06M | — | — | — |
| Total liabilities | $2.16M | $5.30M | $4.21M | $353,326 | $193,202 |
| Shareholders' equity | -$2.14M | -$5.14M | -$1.95M | $1.93M | $2.42M |
| Shares outstanding | 46.88M | 46.88M | 46.88M | 46.88M | 46.88M |
| Cash flow statement | |||||
| Operating cash flow | -$167,633 | -$271,964 | -$348,283 | -$182,320 | -$180,928 |
| Investing cash flow | — | -$250,000 | -$250,000 | — | — |
| Financing cash flow | $161,867 | $475,000 | $645,000 | $180,000 | $100,000 |
| Stock-based compensation | $8,838 | $40,200 | $302,890 | $282,662 | $272,766 |
Free plan shows the latest 5 periods; Pro shows all 9 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.